Expanding the phenotypic spectrum of CSNK2A1-associated Okur-Chung neurodevelopmental syndrome

被引:0
作者
Ramadesikan, Swetha [1 ]
Showpnil, Iftekhar A. [1 ]
Marhabaie, Mohammad [1 ]
Daley, Allison [1 ]
Varga, Elizabeth A. [1 ]
Gurusamy, Umamaheswaran [1 ]
Pastore, Matthew T. [2 ,3 ]
Sites, Emily R. [2 ]
Manickam, Murugu [2 ,3 ]
Bartholomew, Dennis W. [2 ,3 ]
Hunter, Jesse M. [1 ,3 ]
White, Peter [1 ,3 ]
Wilson, Richard K. [1 ,3 ]
Stottmann, Rolf W. [1 ,3 ]
Koboldt, Daniel C. [1 ,3 ]
机构
[1] Nationwide Childrens Hosp, Steve & Cindy Rasmussen Inst Genom Med, Res Inst, Columbus, OH 43205 USA
[2] Nationwide Childrens Hosp, Div Genet & Genom Med, Columbus, OH USA
[3] Ohio State Univ, Coll Med, Dept Otolaryngol, Columbus, OH 43210 USA
来源
HUMAN GENETICS AND GENOMICS ADVANCES | 2025年 / 6卷 / 01期
关键词
PROTEIN-KINASE CK2; CATALYTIC-SUBUNIT; ABNORMALITIES; MUTATIONS; CSNK2A1;
D O I
10.1016/j.xhgg.2024.100379
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
De novo variants in CSNK2A1 cause autosomal dominant Okur-Chung neurodevelopmental syndrome (OCNDS). OCNDS has an evolving clinical phenotype predominantly characterized by intellectual disability, global delays, dysmorphic features, and immunological manifestations. Microcephaly, defined as a small head circumference, is not widely recognized as a classical clinical presentation. Here, we describe four individuals from three unrelated families who shared several clinical features characteristic of an underlying syndromic neurodevelopmental condition. Trio clinical exome and research genome sequencing revealed that all affected individuals had heterozygous pathogenic missense variants in CSNK2A1. Two variants (c.468T>A p.Asp156Glu and c.149A>G p.Tyr50Cys) were de novo and previously reported, but the third variant (c.137G>T p.Gly46Val) is novel and segregated in two affected individuals in a family. This adds to growing evidence of inherited disease-causing variants in CSNK2A1, an observation reported only twice previously. A detailed phenotypic analysis of our cohort together with those individuals reported in the literature revealed that OCNDS individuals, on average, have a smaller head circumference with one-third presenting with microcephaly. We also show that the incidence of microcephaly is significantly correlated with the location of the variant in the encoded protein. Our findings suggest that small head circumference is a common but under-recognized feature of OCNDS, which may not be apparent at birth.
引用
收藏
页数:10
相关论文
共 31 条
  • [1] Okur V., Cho M.T., Henderson L., Retterer K., Schneider M., Sattler S., Niyazov D., Azage M., Smith S., Picker J., Et al., De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features, Hum. Genet., 135, pp. 699-705, (2016)
  • [2] Owen C.I., Bowden R., Parker M.J., Patterson J., Patterson J., Price S., Sarkar A., Castle B., Deshpande C., Splitt M., Et al., Extending the phenotype associated with the CSNK2A1-related Okur-Chung syndrome-A clinical study of 11 individuals, Am. J. Med. Genet., 176, pp. 1108-1114, (2018)
  • [3] Chiu A.T.G., Pei S.L.C., Mak C.C.Y., Leung G.K.C., Yu M.H.C., Lee S.L., Vreeburg M., Pfundt R., van der Burgt I., Kleefstra T., Et al., Okur-Chung neurodevelopmental syndrome: Eight additional cases with implications on phenotype and genotype expansion, Clin. Genet., 93, pp. 880-890, (2018)
  • [4] Borgo C., D'Amore C., Sarno S., Salvi M., Ruzzene M., Protein kinase CK2: a potential therapeutic target for diverse human diseases, Signal Transduct. Targeted Ther., 6, (2021)
  • [5] Gotz C., Montenarh M., Protein kinase CK2 in development and differentiation, Biomed. Rep., 6, pp. 127-133, (2017)
  • [6] St-Denis N.A., Litchfield D.W., Protein kinase CK2 in health and disease: From birth to death: the role of protein kinase CK2 in the regulation of cell proliferation and survival, Cell. Mol. Life Sci., 66, pp. 1817-1829, (2009)
  • [7] Litchfield D.W., Protein kinase CK2: structure, regulation and role in cellular decisions of life and death, Biochem. J., 369, pp. 1-15, (2003)
  • [8] Meggio F., Pinna L.A., One-thousand-and-one substrates of protein kinase CK2?, Faseb. J., 17, pp. 349-368, (2003)
  • [9] Dominguez I., Cruz-Gamero J.M., Corasolla V., Dacher N., Rangasamy S., Urbani A., Narayanan V., Rebholz H., Okur-Chung neurodevelopmental syndrome-linked CK2α variants have reduced kinase activity, Hum. Genet., 140, pp. 1077-1096, (2021)
  • [10] Lou D.Y., Dominguez I., Toselli P., Landesman-Bollag E., O'Brien C., Seldin D.C., The alpha catalytic subunit of protein kinase CK2 is required for mouse embryonic development, Mol. Cell Biol., 28, pp. 131-139, (2008)